Austrianova

Austrianova

Private
SingaporeHealthcare & Life Scienceshttps://austrianova.com/

Last Round

VC Round

Mar 1, 2023

Total Funding Raised

$46.9M

Company Overview

Austrianova is a biotechnology company that provides cell encapsulation technology and services for the development of novel therapies and products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

cell encapsulationCell-in-a-Boxallogeneic cell therapyoff-the-shelf cell therapydrug delivery platformliving medicinecell therapy manufacturingCDMOCMOCROGMP cell bankingcell line developmentimplantable bioreactorcellulose sulphate encapsulationBac-in-a-Boxfill and finish services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Austrianova Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Austrianova Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 1, 2023
VC RoundJul 7, 2021
PIPEApr 22, 2021
Series BJun 5, 2007

Key People

Founding team and executive leadership

Brian Salmons

CEO

Executive Team

Austrianova Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2023

    Led by Checkmate Capital

  • Jul 7, 2021

    Raised VC Round led by Real Tech Fund.

Austrianova Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Austrianova Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Austrianova's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range1
Year Founded2007
Last FundingMar 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.